Literature DB >> 10445219

Chromium homeostasis in patients with type II (NIDDM) diabetes.

B W Morris1, S MacNeil, C A Hardisty, S Heller, C Burgin, T A Gray.   

Abstract

The purpose of this study was to assess chromium handling in non-insulin dependent diabetic patients (NIDDM) compared to healthy volunteers. Chromium handling was evaluated using fasting blood and second morning void urine samples from 93 NIDDM patients and 33 healthy volunteers. Significant differences in chromium homeostasis were seen between patients and controls. NIDDM patients had mean levels of plasma chromium around 33% lower and urine values almost 100% higher than those found in health. Healthy volunteers showed a significant negative correlation between fasting levels of plasma chromium and insulin. This was not evident in NIDDM patients. In the early years of onset of NIDDM, plasma chromium values were inversely correlated with plasma glucose. This was lost in patients with diabetes of more than 2 years duration. We suggest large losses of chromium over many years may exacerbate an already compromised chromium status in NIDDM patients and might contribute to the developing insulin resistance seen in patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445219     DOI: 10.1016/S0946-672X(99)80024-8

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  13 in total

1.  Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats.

Authors:  Buffie J Clodfelder; Bryan M Gullick; Henry C Lukaski; Yasmin Neggers; John B Vincent
Journal:  J Biol Inorg Chem       Date:  2004-12-30       Impact factor: 3.358

2.  Monitoring blood glucose levels in female mink during the reproductive cycle: 1. Prevention of hyperglycemia during the nursing period.

Authors:  Amber M J Hynes; Kirsti Rouvinen-Watt
Journal:  Can J Vet Res       Date:  2007-10       Impact factor: 1.310

3.  Monitoring blood glucose levels in female mink during the reproductive cycle: 2. Effects of short-term fish oil, chromium picolinate, and acetylsalicylic acid supplementation during late lactation.

Authors:  Amber M J Hynes; Kirsti Rouvinen-Watt
Journal:  Can J Vet Res       Date:  2007-10       Impact factor: 1.310

4.  Chromium supplementation improves glucose tolerance in diabetic Goto-Kakizaki rats.

Authors:  Aicha Abdourahman; John G Edwards
Journal:  IUBMB Life       Date:  2008-08       Impact factor: 3.885

Review 5.  The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent.

Authors:  John B Vincent
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

6.  Trace elements in glucometabolic disorders: an update.

Authors:  Nicolas Wiernsperger; Jeanrobert Rapin
Journal:  Diabetol Metab Syndr       Date:  2010-12-19       Impact factor: 3.320

7.  The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons.

Authors:  Ewa Wysocka; Maciej Cymerys; Grzegorz Mielcarz; Wiesław Bryl; Sylwia Dzięgielewska; Lech Torliński
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

8.  Maternal Chromium Restriction Leads to Glucose Metabolism Imbalance in Mice Offspring through Insulin Signaling and Wnt Signaling Pathways.

Authors:  Qian Zhang; Xiaofang Sun; Xinhua Xiao; Jia Zheng; Ming Li; Miao Yu; Fan Ping; Zhixin Wang; Cuijuan Qi; Tong Wang; Xiaojing Wang
Journal:  Int J Mol Sci       Date:  2016-10-22       Impact factor: 5.923

9.  Inverse Association of Plasma Chromium Levels with Newly Diagnosed Type 2 Diabetes: A Case-Control Study.

Authors:  Sijing Chen; Xiaoling Jin; Zhilei Shan; Shuzhen Li; Jiawei Yin; Taoping Sun; Cheng Luo; Wei Yang; Ping Yao; Kaifeng Yu; Yan Zhang; Qian Cheng; Jinquan Cheng; Wei Bao; Liegang Liu
Journal:  Nutrients       Date:  2017-03-17       Impact factor: 5.717

10.  Effect of a fermented dietary supplement containing chromium and zinc on metabolic control in patients with type 2 diabetes: a randomized, placebo-controlled, double-blind cross-over study.

Authors:  Yu-Mi Lee; Petra Wolf; Hans Hauner; Thomas Skurk
Journal:  Food Nutr Res       Date:  2016-06-23       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.